Your right snupoled, this is not average OTC stock, it's got revenue, audited but more to come with S-1 and technology. Who would not buy RXMD, one would lose if they don't buy more or hold like I am. I am heavily invested in another OTC from 2015 at .31 and it's up a lot so I am holding there too. My pay grade you know - GLTU Snup